#21: Stock News Bot: BTIM Stock NEws, BioTime CEO Dr. Michael West to Present Keynote Address at China-USA Scientific Forum of Stem Cell and Regenerative Medicine
Sep. 18, 2009 (Business Wire) -- BioTime, Inc. (OTCBB:BTIM stock news) Chief
... |
September 21, 2009
06:19:29 PM |
#20: Stock News Bot: BTIM Stock News, BioTime CEO Dr. Michael West to Present at World Stem Cells & Regenerative Medicine Congress 2009 and Discuss New Cell Lines with Cartilage-Forming Potential
BioTime, Inc. (OTCBB: BTIM stock news) Chief Executive Officer Michael West, Ph.D.... |
May 8, 2009
02:49:50 PM |
#19: Stock News Bot: BTIM BioTime Launches New Stem Cell Lines in Anticipation of President Obama’s Removal of Restrictions on Federal Funding of Embryonic Stem Cell Research
New Cell Line Products to be Presented at Stem Cells World Conference
... |
January 21, 2009
02:24:09 PM |
#18: Stock News Bot: BTIM Stock: BioTime CEO Dr. Michael West Presents Keynote Address at Event Commemorating the 10th Anniversary of the First Derivation of Human Embryonic Stem Cells
BioTime, Inc. (OTCBB:BTIM stock) Chief Executive Officer Michael West, Ph.D.
... |
November 18, 2008
09:54:26 PM |
#17: Stock News Bot: BTIM Stock: BioTime Announces Collaboration With the International Longevity Center
BioTime, Inc. (OTCBB:BTIM stock) and the International
Longevity... |
October 13, 2008
01:33:10 PM |
#14: Stock News Bot: BioTime CEO Dr. Michael West Presents at 2008 Seoul Digital Forum
Embryonic Stem Cell Research Discussed in Biotechnology
``Visionaries''... |
May 6, 2008
10:54:45 PM |
#13: Stock News Bot: BioTime Opens New GMP Laboratory for Production of Embryonic Stem Cell Technology Products
BioTime Opens New GMP Laboratory for Production of Embryonic Stem Cell Technology... |
April 16, 2008
08:47:23 AM |
#12: Stock News Bot: BioTime, Inc. Announces Plan to Map the Human Embryome
BioTime, Inc. (OTCBB:BTIM) announced its plan to build a relational database for... |
December 18, 2007
09:11:40 AM |
#11: Stock News Bot: BioTime, Inc. Announces the Formation of Embryome Sciences, Inc. for the Development and Commercialization of Stem Cell Technology
BioTime, Inc. (OTCBB:BTIM) today announced that it has organized a new
... |
December 14, 2007
07:00:35 AM |
#10: Stock News Bot: BTIM News BioTime Announces a Phase II Clinical Trial of Hextend(R) in Japan
EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM) announced today... |
December 7, 2006
05:00:00 AM |
#9: Stock News Bot: BTIM News BioTime Announces Results for Third Quarter 2006
EMERYVILLE, Calif.--(BUSINESS WIRE)--BioTime, Inc. (OTCBB:BTIM) today announced... |
November 15, 2006
11:10:00 AM |
#8: Stock News Bot: BTIM News BioTime Announces Results for Second Quarter 2006
EMERYVILLE, Calif.--(BUSINESS WIRE)--Aug. 16, 2006--BioTime, Inc. (OTCBB:BTIM):... |
August 16, 2006
03:30:00 AM |
#7: Stock News Bot: BTIM News BioTime Raises $1,787,145 in Rights Offer
EMERYVILLE, Calif.--(BUSINESS WIRE)--Dec. 22, 2005--BioTime, Inc. (OTCBB:BTIM)... |
December 22, 2005
08:38:00 AM |
#6: Stock News Bot: BTIM News BioTime Announces Sublicense Arrangement for Japan With Maruishi Pharmaceutical Co., Ltd.
EMERYVILLE, Calif.--(BUSINESS WIRE)--Dec. 20, 2005--BioTime, Inc. (OTCBB:BTIM)... |
December 20, 2005
03:41:00 PM |
#5: Stock News Bot: BTIM News BioTime Amends Terms of Subscription Rights Offer
EMERYVILLE, Calif.--(BUSINESS WIRE)--Nov. 29, 2005--BioTime, Inc. (OTCBB:BTIM)... |
November 29, 2005
07:02:00 AM |
